VYNE
#4529
VYNE Therapeutics Inc. - Common Stock
0.7 6 USD
+0.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+7.04%
Monthly Change
+24.59%
6 month change
+33.33%
Year Change
-42.42%
Previous Close
0.7 1
Open
0.7 7
Low
0.7 6
High
0.7 7
Volume
119
Financials
- Market Capitalization 25.35 M
- Employee 10
- Founded 2003
- CEO N/A
- Website www.vynetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00H5W8GM8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4516 |  IGC IGC Pharma, Inc. Common Stock | 0.27 USD | 0.00% | -3.57% | -6.90% | +5.39% | 27.02 M USD | ||
| 4522 |  GRDX GridAI Technologies Corp. - Common Stock | 4.08 USD | +6.25% | -5.12% | -14.82% | +60.00% | 27.14 M USD | ||
| 4536 |  EVAX Evaxion A/S - American Depositary Share | 3.05 USD | +0.33% | -8.96% | -14.08% | -8.13% | 25.44 M USD | ||
| 4540 |  BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.65 USD | +6.56% | +1.56% | -7.14% | -36.27% | 26.55 M USD |
Frequently asked questions about VYNE Therapeutics Inc. - Common Stock
What is the VYNE Therapeutics Inc. - Common Stock stock price today?
The current price of VYNE Therapeutics Inc. - Common Stock (VYNE) is 0.76. Over the past 24 hours, the stock has changed by +7.04%. Follow the VYNE chart for real-time price dynamics.
What is the stock ticker of VYNE Therapeutics Inc. - Common Stock?
VYNE Therapeutics Inc. - Common Stock trades under the ticker VYNE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is VYNE Therapeutics Inc. - Common Stock stock going up?
VYNE has changed by +16.92% over the last week, +24.59% over the last month, and -42.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was VYNE Therapeutics Inc. - Common Stock net income for the last quarter?
VYNE Therapeutics Inc. - Common Stock reported net income of -3.58 M for the last quarter. The previous quarter showed 7.55 M, which means net income changed by -147.48%.
How many employees does VYNE Therapeutics Inc. - Common Stock have?
As of the latest available data, VYNE Therapeutics Inc. - Common Stock has 10 employees. Workforce size can provide additional context about the company's scale and operations.
What is VYNE Therapeutics Inc. - Common Stock EBITDA?
VYNE Therapeutics Inc. - Common Stock EBITDA is -3.81 M, and its EBITDA margin is -4 430.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy VYNE Therapeutics Inc. - Common Stock stock?
You can buy VYNE Therapeutics Inc. - Common Stock (VYNE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in VYNE Therapeutics Inc. - Common Stock stock?
Investing in VYNE Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VYNE chart and related analysis on metatrader.com as part of your research.